Moderna Inc (MRNA)

$56.99 +1.85 (3.36%)
Market Cap 21.88B
Revenue (ttm) 1.94B
Net Income (ttm) -2.82B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -145.16%
Debt to Equity Ratio 0.09
Volume 3,999,800
Avg Vol 7,180,106
Day's Range N/A - N/A
Shares Out 396.79M
Stochastic %K 63%
Beta 0.91
Analysts Hold
Price Target $52.05

Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseas...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 714 6500
Address:
325 Binney Street, Cambridge, United States
LisaAndrews125
LisaAndrews125 Aug. 5 at 7:26 AM
$DJIA $MRNA $MRAM $LAES $AG DJIA tracks major blue-chip companies, Moderna expands its mRNA platform, MRAM technology benefits from advanced memory demand, LAES remains growth-oriented, and First Majestic benefits from silver prices.
0 · Reply
BioRich
BioRich Aug. 5 at 2:23 AM
$REPL For those looking for useful links, hopefully this helps: NASDAQ Halts: https://www.nasdaqtrader.com/trader.aspx?id=tradehalts FDA Approvals: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process FDA CRLs: https://open.fda.gov/crltable/ Not bad to have these available for the upcoming FDA decisions for $CAPR, $NRXP, $MRNA and $JAZZ. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
0 · Reply
Samishere
Samishere Aug. 5 at 1:21 AM
$MRNA
0 · Reply
IndyOne
IndyOne Aug. 5 at 1:03 AM
$MRNA Robert F. Kennedy, Jr. urging parents to vaccinate kids against measles https://share.google/ibU4O0YKp2qpo2Qti
0 · Reply
La_Parka3
La_Parka3 Aug. 5 at 12:53 AM
$MRNA “85 year old Dr Fauci made me take the vaccine and the needle hurts.”
1 · Reply
La_Parka3
La_Parka3 Aug. 5 at 12:27 AM
$MRNA I am sensing a bit of Fredo vibe.
1 · Reply
La_Parka3
La_Parka3 Aug. 4 at 11:31 PM
$MRNA “I did my research on vaccines.” Just found a pic of this antivaxer doing his research.
1 · Reply
SargeMaximus2
SargeMaximus2 Aug. 4 at 9:54 PM
$MRNA Not above 57.70?
0 · Reply
Sukitt
Sukitt Aug. 4 at 9:16 PM
https://stocktwits.com/news-articles/markets/equity/mrna-lnth-bmy-capr-rare-stocks-in-focus-these-fda-decisions-could-shape-august-trading/cZoTYS7RJ30 $MRNA $CAPR
0 · Reply
discussionbo7
discussionbo7 Aug. 4 at 8:52 PM
$MRNA $PLTR $CRWV do i ever miss???? $ANET
0 · Reply
Latest News on MRNA
Moderna Stock Jumps on Trial Launch for Breakthrough Ebola Vaccine

Aug 4, 2026, 12:35 PM EDT - 16 hours ago

Moderna Stock Jumps on Trial Launch for Breakthrough Ebola Vaccine

Moderna announces initiation of Phase 1 trial of mRNA-1469

2026-08-04T15:05:23.000Z - 18 hours ago

Moderna announces initiation of Phase 1 trial of mRNA-1469

Moderna begins first human trial of Bundibugyo Ebola vaccine

Aug 4, 2026, 11:03 AM EDT - 18 hours ago

Moderna begins first human trial of Bundibugyo Ebola vaccine

Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus

Aug 4, 2026, 11:00 AM EDT - 18 hours ago

Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus

Moderna price target raised to $60 from $41 at Citi

2026-08-03T10:41:57.000Z - 1 day ago

Moderna price target raised to $60 from $41 at Citi

Moderna Wins a Post-COVID Earnings Beat as Analyst Eyes ‘Clinically Meaningful’ Trial Results

2026-07-31T15:04:57.000Z - 4 days ago

Moderna Wins a Post-COVID Earnings Beat as Analyst Eyes ‘Clinically Meaningful’ Trial Results

JEF MRK

Moderna Earnings Call Transcript: Q2 2026

Jul 31, 2026, 8:00 AM EDT - 4 days ago

Moderna Earnings Call Transcript: Q2 2026

Moderna Earnings release: Q2 2026

Jul 31, 2026, 8:00 AM EDT - 4 days ago

Moderna Earnings release: Q2 2026

Moderna Slides: Q2 2026

Jul 31, 2026, 8:00 AM EDT - 4 days ago

Moderna Slides: Q2 2026

Moderna Quarterly report: Q2 2026

Jul 31, 2026, 8:00 AM EDT - 4 days ago

Moderna Quarterly report: Q2 2026

Moderna Narrows Loss, Says New Norovirus Vaccine Didn't Meet Expectations

Jul 31, 2026, 7:45 AM EDT - 4 days ago

Moderna Narrows Loss, Says New Norovirus Vaccine Didn't Meet Expectations

Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

Jul 31, 2026, 7:26 AM EDT - 4 days ago

Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

Moderna sees FY26 cost of sales $1.7B, down from prior $1.8B view

2026-07-31T11:11:53.000Z - 4 days ago

Moderna sees FY26 cost of sales $1.7B, down from prior $1.8B view

Moderna sees potential approval of fifth product for mFLUSIVA

2026-07-31T11:11:22.000Z - 4 days ago

Moderna sees potential approval of fifth product for mFLUSIVA

Moderna reports Q2 EPS ($1.97), consensus ($2.06)

2026-07-31T11:07:09.000Z - 4 days ago

Moderna reports Q2 EPS ($1.97), consensus ($2.06)

Moderna affirms FY26 revenue view of $2.14B, consensus $2.09B

2026-07-31T11:06:31.000Z - 4 days ago

Moderna affirms FY26 revenue view of $2.14B, consensus $2.09B

Moderna still sees FY26 CapEx $200M-$300M

2026-07-31T11:06:25.000Z - 4 days ago

Moderna still sees FY26 CapEx $200M-$300M

Moderna says mRNA-1403 didn’t meet criteria for early success

2026-07-31T11:05:42.000Z - 4 days ago

Moderna says mRNA-1403 didn’t meet criteria for early success

Moderna misses quarterly revenue estimates on COVID vaccine weakness

Jul 31, 2026, 7:04 AM EDT - 4 days ago

Moderna misses quarterly revenue estimates on COVID vaccine weakness

Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates

Jul 31, 2026, 7:00 AM EDT - 4 days ago

Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates

Polymarket Odds: Will MRNA, XOM, CVX Beat Earnings Tomorrow?

2026-07-30T17:47:12.000Z - 5 days ago

Polymarket Odds: Will MRNA, XOM, CVX Beat Earnings Tomorrow?

CVX XOM

Moderna price target raised to $67 from $49 at Goldman Sachs

2026-07-21T09:55:50.000Z - 14 days ago

Moderna price target raised to $67 from $49 at Goldman Sachs

Moderna announces first participant dosed in Phase 1 trial of mRNA-4200

2026-07-16T12:05:59.000Z - 19 days ago

Moderna announces first participant dosed in Phase 1 trial of mRNA-4200

Arbutus Biopharma receives $178M settlement agreement from Moderna

2026-07-16T11:45:13.000Z - 19 days ago

Arbutus Biopharma receives $178M settlement agreement from Moderna

ABUS

Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors

Jul 16, 2026, 7:00 AM EDT - 19 days ago

Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors

Here’s Why Moderna Stock (MRNA) Is Crashing Today — July 10, 2026

2026-07-10T17:31:18.000Z - 25 days ago

Here’s Why Moderna Stock (MRNA) Is Crashing Today — July 10, 2026

JPM MRK

Moderna falls -10.7%

2026-07-10T16:05:38.000Z - 25 days ago

Moderna falls -10.7%

Moderna wins EU contract for RSV vaccine supply

Jul 9, 2026, 7:17 AM EDT - 26 days ago

Moderna wins EU contract for RSV vaccine supply

Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026

Jul 9, 2026, 7:00 AM EDT - 26 days ago

Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026

Moderna Appoints Michael McDonnell to Board of Directors

Jul 8, 2026, 7:00 AM EDT - 27 days ago

Moderna Appoints Michael McDonnell to Board of Directors

Moderna stock jumps as pipeline progress and flu shot data lift sentiment

Jul 2, 2026, 3:51 PM EDT - 4 weeks ago

Moderna stock jumps as pipeline progress and flu shot data lift sentiment

Jim Cramer says this former Covid market darling is finally investable again

Jul 1, 2026, 6:50 PM EDT - 4 weeks ago

Jim Cramer says this former Covid market darling is finally investable again

The 20 best-performing stocks in the S&P 500 for the first half of 2026

Jun 30, 2026, 7:34 AM EDT - 5 weeks ago

The 20 best-performing stocks in the S&P 500 for the first half of 2026

AMD CIEN COHR DELL FIX FLEX GLW

Moderna stock soars as cancer pipeline and CAR-T push ignite optimism

Jun 26, 2026, 2:47 PM EDT - 5 weeks ago

Moderna stock soars as cancer pipeline and CAR-T push ignite optimism

Healthcare stocks have become a haven for investors ditching tech

Jun 26, 2026, 2:39 PM EDT - 5 weeks ago

Healthcare stocks have become a haven for investors ditching tech

ABBV ABSI APGE JNJ LLY SNY XBI

Why Moderna Stock Is Soaring and Leading the S&P 500 Today

Jun 26, 2026, 11:36 AM EDT - 5 weeks ago

Why Moderna Stock Is Soaring and Leading the S&P 500 Today

Moderna Transcript: Science Day 2026

Jun 25, 2026, 9:00 AM EDT - 5 weeks ago

Moderna Transcript: Science Day 2026

Moderna Slides: FY 2026

Jun 25, 2026, 9:00 AM EDT - 5 weeks ago

Moderna Slides: FY 2026

Moderna Science Day Highlights Expanding Potential of mRNA Platform

Jun 25, 2026, 7:00 AM EDT - 5 weeks ago

Moderna Science Day Highlights Expanding Potential of mRNA Platform

FDA Votes in Favor of Benefit-Risk Profile for Moderna's Flu Vaccine

Jun 18, 2026, 4:23 PM EDT - 6 weeks ago

FDA Votes in Favor of Benefit-Risk Profile for Moderna's Flu Vaccine

Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine

Jun 18, 2026, 4:00 PM EDT - 6 weeks ago

Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine

US FDA advisers vote in favor of Moderna's flu vaccine

Jun 18, 2026, 2:48 PM EDT - 6 weeks ago

US FDA advisers vote in favor of Moderna's flu vaccine

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny

Jun 18, 2026, 6:01 AM EDT - 6 weeks ago

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny

Moderna to Host Investor Event - Science Day

Jun 17, 2026, 7:00 AM EDT - 6 weeks ago

Moderna to Host Investor Event - Science Day

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO

Jun 17, 2026, 2:38 AM EDT - 7 weeks ago

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO

BNTX

US FDA staff says data may support effectiveness of Moderna's flu vaccine in older adults

Jun 16, 2026, 9:12 AM EDT - 7 weeks ago

US FDA staff says data may support effectiveness of Moderna's flu vaccine in older adults

Moderna announces executive changes ahead of potential launches

Jun 16, 2026, 8:37 AM EDT - 7 weeks ago

Moderna announces executive changes ahead of potential launches

Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028

Jun 16, 2026, 7:30 AM EDT - 7 weeks ago

Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028

Moderna Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 3:20 PM EDT - 2 months ago

Moderna Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome

Jun 8, 2026, 7:01 PM EDT - 2 months ago

Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

Jun 3, 2026, 8:10 AM EDT - 2 months ago

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

AES ARW BAX EXP EXPD HPQ IESC

Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™”

Jun 2, 2026, 4:34 PM EDT - 2 months ago

Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™”

Moderna to Present at Upcoming Conference in June 2026

Jun 2, 2026, 7:00 AM EDT - 2 months ago

Moderna to Present at Upcoming Conference in June 2026

Moderna Transcript: Study update

Jun 1, 2026, 7:15 PM EDT - 2 months ago

Moderna Transcript: Study update

Moderna Press release: Study update

Jun 1, 2026, 7:15 PM EDT - 2 months ago

Moderna Press release: Study update

Moderna Slides: Study update

Jun 1, 2026, 7:15 PM EDT - 2 months ago

Moderna Slides: Study update

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

Jun 1, 2026, 8:00 AM EDT - 2 months ago

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

MRK

Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine

Jun 1, 2026, 5:37 AM EDT - 2 months ago

Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine

Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

Jun 1, 2026, 5:00 AM EDT - 2 months ago

Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

Moderna Transcript: Bernstein 42nd Annual Strategic Decisions Conference

May 28, 2026, 10:00 AM EDT - 2 months ago

Moderna Transcript: Bernstein 42nd Annual Strategic Decisions Conference

Moderna, Merck cancer combo cuts melanoma spread risk at five years

May 21, 2026, 5:03 PM EDT - 2 months ago

Moderna, Merck cancer combo cuts melanoma spread risk at five years

MRK

US FDA to hold expert committee meeting to review Moderna's flu vaccine

May 21, 2026, 11:26 AM EDT - 2 months ago

US FDA to hold expert committee meeting to review Moderna's flu vaccine

Moderna Transcript: RBC Capital Markets Global Healthcare Conference 2026

May 19, 2026, 10:00 AM EDT - 2 months ago

Moderna Transcript: RBC Capital Markets Global Healthcare Conference 2026

Moderna Recognized by TIME as One of the World's Most Impactful Companies

May 12, 2026, 5:00 PM EDT - 3 months ago

Moderna Recognized by TIME as One of the World's Most Impactful Companies

Moderna Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 2:20 PM EDT - 3 months ago

Moderna Transcript: Bank of America Global Healthcare Conference 2026

Moderna's AI Could Get a Hantavirus Vaccine Here Faster

May 12, 2026, 1:25 PM EDT - 3 months ago

Moderna's AI Could Get a Hantavirus Vaccine Here Faster

Hantavirus outbreak: these 3 stocks are poised to rip higher

May 11, 2026, 11:44 PM EDT - 3 months ago

Hantavirus outbreak: these 3 stocks are poised to rip higher

MMM QDEL

Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging.

May 11, 2026, 8:19 PM EDT - 3 months ago

Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging.

Here's how much Moderna's stock has rallied off renewed focus on hantavirus research

May 11, 2026, 1:17 PM EDT - 3 months ago

Here's how much Moderna's stock has rallied off renewed focus on hantavirus research

Moderna stock soars as hantavirus fears spark outbreak trade

May 11, 2026, 10:44 AM EDT - 3 months ago

Moderna stock soars as hantavirus fears spark outbreak trade

Hantavirus cases spark surge in pharma and biotech stocks — here's why

May 11, 2026, 7:53 AM EDT - 3 months ago

Hantavirus cases spark surge in pharma and biotech stocks — here's why

EBS INO NVAX

Moderna Stock Jumps. U.S. Passenger on Hantavirus Cruise Ship Tests Positive.

May 11, 2026, 5:29 AM EDT - 3 months ago

Moderna Stock Jumps. U.S. Passenger on Hantavirus Cruise Ship Tests Positive.

How Hantavirus Made Moderna a Must-Own Stock Again

May 8, 2026, 2:44 PM EDT - 3 months ago

How Hantavirus Made Moderna a Must-Own Stock Again

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

May 6, 2026, 5:15 PM EDT - 3 months ago

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial

May 6, 2026, 5:01 PM EDT - 3 months ago

Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial

Moderna Transcript: AGM 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Moderna Transcript: AGM 2026

Moderna Earnings Call Transcript: Q1 2026

May 1, 2026, 8:00 AM EDT - 3 months ago

Moderna Earnings Call Transcript: Q1 2026

Moderna Slides: Q1 2026

May 1, 2026, 8:00 AM EDT - 3 months ago

Moderna Slides: Q1 2026

Moderna Quarterly report: Q1 2026

May 1, 2026, 8:00 AM EDT - 3 months ago

Moderna Quarterly report: Q1 2026

Moderna Earnings release: Q1 2026

May 1, 2026, 8:00 AM EDT - 3 months ago

Moderna Earnings release: Q1 2026

Moderna Stock Spikes After Earnings. Covid Vaccine Revenue Is a Growth Driver Again.

May 1, 2026, 7:46 AM EDT - 3 months ago

Moderna Stock Spikes After Earnings. Covid Vaccine Revenue Is a Growth Driver Again.

Moderna Reports Higher Revenue but Posts a Loss

May 1, 2026, 6:37 AM EDT - 3 months ago

Moderna Reports Higher Revenue but Posts a Loss

Moderna tops quarterly revenue estimates on stronger international COVID vaccine sales

May 1, 2026, 6:32 AM EDT - 3 months ago

Moderna tops quarterly revenue estimates on stronger international COVID vaccine sales

LisaAndrews125
LisaAndrews125 Aug. 5 at 7:26 AM
$DJIA $MRNA $MRAM $LAES $AG DJIA tracks major blue-chip companies, Moderna expands its mRNA platform, MRAM technology benefits from advanced memory demand, LAES remains growth-oriented, and First Majestic benefits from silver prices.
0 · Reply
BioRich
BioRich Aug. 5 at 2:23 AM
$REPL For those looking for useful links, hopefully this helps: NASDAQ Halts: https://www.nasdaqtrader.com/trader.aspx?id=tradehalts FDA Approvals: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process FDA CRLs: https://open.fda.gov/crltable/ Not bad to have these available for the upcoming FDA decisions for $CAPR, $NRXP, $MRNA and $JAZZ. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
0 · Reply
Samishere
Samishere Aug. 5 at 1:21 AM
$MRNA
0 · Reply
IndyOne
IndyOne Aug. 5 at 1:03 AM
$MRNA Robert F. Kennedy, Jr. urging parents to vaccinate kids against measles https://share.google/ibU4O0YKp2qpo2Qti
0 · Reply
La_Parka3
La_Parka3 Aug. 5 at 12:53 AM
$MRNA “85 year old Dr Fauci made me take the vaccine and the needle hurts.”
1 · Reply
La_Parka3
La_Parka3 Aug. 5 at 12:27 AM
$MRNA I am sensing a bit of Fredo vibe.
1 · Reply
La_Parka3
La_Parka3 Aug. 4 at 11:31 PM
$MRNA “I did my research on vaccines.” Just found a pic of this antivaxer doing his research.
1 · Reply
SargeMaximus2
SargeMaximus2 Aug. 4 at 9:54 PM
$MRNA Not above 57.70?
0 · Reply
Sukitt
Sukitt Aug. 4 at 9:16 PM
https://stocktwits.com/news-articles/markets/equity/mrna-lnth-bmy-capr-rare-stocks-in-focus-these-fda-decisions-could-shape-august-trading/cZoTYS7RJ30 $MRNA $CAPR
0 · Reply
discussionbo7
discussionbo7 Aug. 4 at 8:52 PM
$MRNA $PLTR $CRWV do i ever miss???? $ANET
0 · Reply
bullishhype
bullishhype Aug. 4 at 7:13 PM
$NVO my feeling is some institutions will pull back big by morning! It already had $MRNA momentum!
0 · Reply
IndyOne
IndyOne Aug. 4 at 6:56 PM
$MRNA O Canada! Our home and native land! True patriot love in all of us command. With glowing hearts we see thee rise, The True North strong and free! Health Canada authorizes Moderna clinical trial for new Ebola vaccine candidate https://www.thestar.com/news/canada/health-canada-authorizes-moderna-clinical-trial-for-new-ebola-vaccine-candidate/article_15c469cc-80f9-5deb-833b-c7cbf58b461d.html
2 · Reply
fastengels
fastengels Aug. 4 at 5:50 PM
$MRNA
1 · Reply
fastengels
fastengels Aug. 4 at 5:44 PM
$MRNA
1 · Reply
IndyOne
IndyOne Aug. 4 at 5:11 PM
$MRNA Moderna Stock Jumps on Trial Launch for Breakthrough Ebola Vaccine more news coming https://www.barrons.com/articles/moderna-stock-ebola-vaccine-trial-7ca1852c?reflink=desktopwebshare_permalink
0 · Reply
Samishere
Samishere Aug. 4 at 5:03 PM
$MRNA Top notch makers of ,,,,
0 · Reply
Samishere
Samishere Aug. 4 at 4:58 PM
$MRNA Found your profile pic,, you may wanna give those boosters a break for awhile 🤪
1 · Reply
StocktwitsNews
StocktwitsNews Aug. 4 at 4:47 PM
Moderna Doses First Participants In Ebola Vaccine Trial Ahead Of Key FDA Decision On Flu Shot $MRNA https://stocktwits.com/news/equity/markets/mrna-stock-rises-moderna-ebola-trial-starts-flu-vaccine-fda-decision/cZo5Y4jRJ45
0 · Reply
IndyOne
IndyOne Aug. 4 at 3:55 PM
$MRNA "Vaccinating the first participants with mRNA-1469 marks an important milestone in advancing a vaccine candidate against Bundibugyo ebolavirus, for which no approved vaccine currently exists," said Stéphane Bancel, Chief Executive Officer of Moderna. "We are grateful to CEPI, Health Canada, the investigators and study participants for their contributions to advance this work." The hearty thanks to Canada may get a reaction from President Trump. Not too late Mr President, to do the right thing.
3 · Reply
IndyOne
IndyOne Aug. 4 at 3:42 PM
$MRNA Mr. President, "Time for an Ebola Czar." 1. Largest Ebola outbreak on record 2. 3,695 confirmed cases and 1,623 deaths 3. Spread to five provinces: Ituri, North Kivu, South Kivu, Haut-Uélé, and Tshopo. .cc Rubio
1 · Reply
MobyOneCanobi
MobyOneCanobi Aug. 4 at 3:32 PM
$MRNA Moderna starts phase 1 of Ebola vaccine. https://www.reddit.com/r/ModernaStock/s/nDoC52oxyc
0 · Reply
IndyOne
IndyOne Aug. 4 at 2:53 PM
$MRNA Noice
0 · Reply